Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Others
    • Ex-Fortis Promoter...

    Ex-Fortis Promoter Malvinder Singh, Former Religare Executive Godhwani Sent To Judicial Custody

    Written by Garima Published On 2019-11-24T17:09:46+05:30  |  Updated On 24 Nov 2019 5:09 PM IST

    Mr Singh and Mr Godhwani have been accused of laundering money, punishable under Sections 3 and 4 of the Prevention of Money Laundering Act, the central agency added.

    NEW DELHI: A Delhi court on Saturday sent former Fortis Healthcare promoter Malvinder Singh and former CMD of Religare Enterprises Limited Sunil Godhwani to judicial custody in an alleged money laundering case related to alleged misappropriation of funds at Religare Finvest Limited (RFL).

    Special Judge Sandeep Yadav sent them to custody till December 7 after they were produced before a court on expiry of their custodial interrogation by the Enforcement Directorate (ED).

    The ED special public prosecutor Nitesh Rana sought further custodial interrogation, saying more information has emerged and they need to be questioned.

    However, the court dismissed the application saying "further custodial interrogation is neither required nor warranted."

    The agency had taken both into custody on November 14 from Tihar jail, where they had been lodged due to a case filed by the Delhi Police in relation to the alleged scam, advocate AR Aditya, also appearing for the agency, said.

    Mr Singh and Mr Godhwani have been accused of laundering money, punishable under Sections 3 and 4 of the Prevention of Money Laundering Act, the central agency added.

    IANS in its recent report unfolded Singh Brothers’ alleged modus operandi to strip Religare Finvest Ltd. (RFL) bare. The construct of fund diversion was a carefully assessed plan, wherein, original loans were made to various companies which as a matter of fact was controlled by Singh brothers’ stockbroker, N.K. Ghoshal. All these companies were found to be apparently connected and acting as one economic unit.

    These companies use to transferring the loan amounts received from RFL to other intermediary companies, allegedly at the order of RFL, to facilitate repayment of loans obtained from it by other third parties, within hours of the receipt of the loan amounts.

    A few of the intermediaries identified in the case includes one Platinum Infrastructure Pvt. Ltd. It is believed on the basis of internal inquiries that Platinum is eventually controlled by Singh Brothers. Platinum admitted that its bank accounts statements revealed that a sum of Rs 109.30 crore was received by it, but, the said funds were transferred from its account to another entity known as Prius Real Estate Ltd. Prius Real Estate is also understood to be an entity controlled by Singh Brothers.

    Read Also: Religare Fund Diversion: How It All Happened

    Delhi Policefund diversion caseMalvinder Mohan Singhnk ghoshalPlatinum InfrastructureReligarereligare finvest ltdreligare groupRFLShivinder Mohan SinghSingh brothersSunil Godhwani

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok